Search Results - "Drakou, Athina"
-
1
Creatinine index as a predictive marker of sarcopenia in patients under hemodialysis
Published in International urology and nephrology (01-07-2022)“…Purpose Sarcopenia is a clinical condition that comprises declined skeletal muscle (SM) mass and SM strength, and is a risk factor for physical disability,…”
Get full text
Journal Article -
2
MO907ASSOCIATION OF ADIPOSITY AND SARCOPENIA WITH CARDIAC VALVE CALCIFICATION IN PATIENTS ON MAINTENANCE HEMODIALYSIS. A CROSS-SECTIONAL STUDY
Published in Nephrology, dialysis, transplantation (29-05-2021)“…Abstract Background and Aims Cardiac valve calcification (CVC) is a common disorder in patients with end stage kidney disease (ESKD) and is a predictor of…”
Get full text
Journal Article -
3
Assessment of Serum Bioactive Hepcidin-25, Soluble Transferrin Receptor and Their Ratio in Predialysis Patients: Correlation with the Response to Intravenous Ferric Carboxymaltose Administration
Published in Blood (03-12-2015)“…Background: No reliable biomarker exists to predict responsiveness to intravenous (IV) iron (Fe) in iron deficient patients with chronic kidney disease (CKD)…”
Get full text
Journal Article -
4
Cardiac valve calcification in patients on maintenance dialysis. The role of malnutrition-inflammation syndrome, adiposity andcomponents of sarcopenia. A cross-sectional study
Published in Clinical nutrition ESPEN (01-12-2022)“…Cardiac valve calcification (CVC) is a predictor of cardiovascular disease and all-cause mortality in end stage kidney disease (ESKD) patients. Several risk…”
Get full text
Journal Article -
5
MP372USE OF DENUSUMAB IN END STAGE RENAL DISEASE
Published in Nephrology, dialysis, transplantation (01-05-2016)Get full text
Journal Article -
6
Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose
Published in Blood cells, molecules, & diseases (01-07-2016)“…No reliable biomarker exists to predict responsiveness to intravenous (IV) iron (Fe) in iron deficient patients with CKD. We aimed to investigate the clinical…”
Get full text
Journal Article -
7
Spironolactone improves endothelial and cardiac autonomic function in non heart failure hemodialysis patients
Published in Journal of hypertension (01-06-2013)“…OBJECTIVES:Hemodialysis patients have a cardiovascular mortality rate of 20–40 times that of the general population. Aldosterone inhibition by spironolactone…”
Get full text
Journal Article -
8